Paul M. Jordan - Search Results

Year	Number of Results
2015	1
2017	1
2018	1
2019	3
2020	4
2021	13
2022	15
2023	15
2024	7

1

Novel 1,3,4-oxadiazole derivatives as highly potent microsomal prostaglandin E₂ synthase-1 (mPGES-1) inhibitors.

Gür Maz T, Dahlke P, Gizem Ergül A, Olğaç A, Jordan PM, Çalışkan B, Werz O, Banoglu E. Gür Maz T, et al. Among authors: jordan pm. Bioorg Chem. 2024 Apr 16;147:107383. doi: 10.1016/j.bioorg.2024.107383. Online ahead of print. Bioorg Chem. 2024. PMID: 38653151

2

Structure Revision of a Widespread Marine Sulfonolipid Class Based on Isolation and Total Synthesis.

Roman D, Meisinger P, Guillonneau R, Peng CC, Peltner LK, Jordan PM, Haensch V, Götze S, Werz O, Hertweck C, Chen Y, Beemelmanns C. Roman D, et al. Among authors: jordan pm. Angew Chem Int Ed Engl. 2024 Mar 26:e202401195. doi: 10.1002/anie.202401195. Online ahead of print. Angew Chem Int Ed Engl. 2024. PMID: 38529534

3

Correction: Encapsulation of the dual FLAP/mPEGS‑1 inhibitor BRP‑187 into acetalated dextran and PLGA nanoparticles improves its cellular bioactivity.

Shkodra B, Kretzer C, Jordan PM, Klemm P, Koeberle A, Pretzel D, Banoglu E, Lorkowski S, Wallert M, Höppener S, Stumpf S, Vollrath A, Schubert S, Werz O, Schubert US. Shkodra B, et al. Among authors: jordan pm. J Nanobiotechnology. 2024 Feb 27;22(1):77. doi: 10.1186/s12951-024-02341-7. J Nanobiotechnology. 2024. PMID: 38408973 Free PMC article. No abstract available.

4

PEG-Lipid-PLGA Hybrid Particles for Targeted Delivery of Anti-Inflammatory Drugs.

Ismail J, Klepsch LC, Dahlke P, Tsarenko E, Vollrath A, Pretzel D, Jordan PM, Rezaei K, Czaplewska JA, Stumpf S, Beringer-Siemers B, Nischang I, Hoeppener S, Werz O, Schubert US. Ismail J, et al. Among authors: jordan pm. Pharmaceutics. 2024 Jan 28;16(2):187. doi: 10.3390/pharmaceutics16020187. Pharmaceutics. 2024. PMID: 38399248 Free PMC article.

5

The acute effects of pre- and mid-exercise carbohydrate ingestion on the immunoregulatory stress hormone release in experienced endurance athletes-a systematic review.

Christ T, Ringleb M, Haunhorst S, Fennen L, Jordan PM, Wagner H, Puta C. Christ T, et al. Among authors: jordan pm. Front Sports Act Living. 2024 Jan 26;6:1264814. doi: 10.3389/fspor.2024.1264814. eCollection 2024. Front Sports Act Living. 2024. PMID: 38362064 Free PMC article. Review.

6

Influenza A virus selectively elevates prostaglandin E₂ formation in pro-resolving macrophages.

Jordan PM, Günther K, Nischang V, Ning Y, Deinhardt-Emmer S, Ehrhardt C, Werz O. Jordan PM, et al. iScience. 2023 Dec 26;27(1):108775. doi: 10.1016/j.isci.2023.108775. eCollection 2024 Jan 19. iScience. 2023. PMID: 38261967 Free PMC article.

7

Frankincense preparation promotes formation of inflammation-resolving lipid mediators by manipulating lipoxygenases in human innate immune cells.

Nischang V, Witt FM, Börner F, Gomez M, Jordan PM, Werz O. Nischang V, et al. Among authors: jordan pm. Front Pharmacol. 2024 Jan 4;14:1332628. doi: 10.3389/fphar.2023.1332628. eCollection 2023. Front Pharmacol. 2024. PMID: 38239198 Free PMC article.

8

Characterization of Different Inflammatory Skin Conditions in a Mouse Model of DNCB-Induced Atopic Dermatitis.

Riedl R, Kühn A, Hupfer Y, Hebecker B, Peltner LK, Jordan PM, Werz O, Lorkowski S, Wiegand C, Wallert M. Riedl R, et al. Among authors: jordan pm. Inflammation. 2023 Dec 27. doi: 10.1007/s10753-023-01943-x. Online ahead of print. Inflammation. 2023. PMID: 38150167

9

Differential impact of 5-lipoxygenase-activating protein antagonists on the biosynthesis of leukotrienes and of specialized pro-resolving mediators.

Dahlke P, Peltner LK, Jordan PM, Werz O. Dahlke P, et al. Among authors: jordan pm. Front Pharmacol. 2023 Aug 23;14:1219160. doi: 10.3389/fphar.2023.1219160. eCollection 2023. Front Pharmacol. 2023. PMID: 37680719 Free PMC article.

10

Substituted 1,2,4-Triazoles as Novel and Selective Inhibitors of Leukotriene Biosynthesis Targeting 5-Lipoxygenase-Activating Protein.

Olğaç A, Çapan İ, Dahlke P, Jordan PM, Werz O, Banoglu E. Olğaç A, et al. Among authors: jordan pm. ACS Omega. 2023 Aug 18;8(34):31293-31304. doi: 10.1021/acsomega.3c03682. eCollection 2023 Aug 29. ACS Omega. 2023. PMID: 37663492 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

52 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year